Sang Hyuk Lee

Sang Hyuk Lee

Auto-generated profile, based on publicly available information

Sang Hyuk Lee

Department of Otorhinolaryngology-Head and Neck Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
CRChang Hwan Ryu
Chang Hwan Ryu
TKTack-Kyun Kwon
Tack-Kyun Kwon
HKHee Jin Kim
Hee Jin Kim
HKHan Su Kim
Han Su Kim
IPIl-Seok Park
Il-Seok Park
SCSeung-Ho Choi
Seung-Ho Choi
The Korean Society of Laryngology, Phoniatrics and Logopedics appointed a task force to establish clinical practice guidelines for the management of unilateral vocal fold paralysis (UVFP). These guidelines cover a comprehensive range of management-related factors, including the diagnosis and treatment of UVFP, and provide in-depth information based on current, up-to-date knowledge. Detailed evidence profiles are provided for each recommendation. The CORE databases, including OVID Medline, Embase, the Cochrane Library, and KoreaMed, were searched to identify all relevant papers, using a predefined search strategy. When insufficient evidence existed, expert opinions and Delphi questionnaires were used to fill the evidence gap. The committee developed 16 evidence-based recommendations in six categories: initial evaluation (R1–4), spontaneous recovery (R5), medical treatment (R6), surgical treatment (R7–14), voice therapy (R15), and aspiration prevention (R16). The goal of these guidelines is to assist general otolaryngologists and speech-language pathologists who are primarily responsible for treating patients with UVFP. These guidelines are also intended to facilitate understanding of the condition among other health-care providers, including primary care physicians, nurses, and policy-makers.

1 January 2013 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
SWSeung Hoon Woo
Seung Hoon Woo
JKJin Pyeong Kim
Jin Pyeong Kim
JPJung Je Park
Jung Je Park
PCPhil-Sang Chung
Phil-Sang Chung
SLSang-Hyuk Lee
Sang-Hyuk Lee
HJHan-sin Jeong
Han-sin Jeong
Woo SH, et al. Yonsei Med J. 2013 Nov;54(6):1516-1523. https://doi.org/10.3349/ymj.2013.54.6.1516

1 December 2022 in Endocrine-Related Cancer
Verified
Journal Article
Closed access
PDF file
TKTae Hwan Kim
Tae Hwan Kim
MLMi Yeon Lee
Mi Yeon Lee
SJSung Min Jin
Sung Min Jin
SLSang Hyuk Lee
Sang Hyuk Lee
The impact of serum thyroid hormone levels on thyroid cancer risk is unclear. Some studies reported that elevated thyroid-stimulating hormone (TSH) is associated with higher risk for incidence of thyroid cancer, but other studies reported no relationship. We conducted a large cohort study in 164,596 South Korean men and women who were free of thyroid cancer at baseline and underwent health examination with hormone levels of thyroid function. A parametric proportional hazard model was used to evaluate the adjusted hazard ratio (HR) and 95% CI. During 2,277,749.78 person-years of follow-up, 1280 incident thyroid cancers were identified (men = 593, women = 687). Among men, the multivariable-adjusted HR (95% CI) for thyroid cancer comparing low levels of TSH with normal levels of TSH was 2.95 (1.67–5.23), whereas the corresponding HR (95% CI) in women was 1.5 (0.88–2.55). High levels of free T4 and free T3 were also associated with incident thyroid cancer in both men and women. In clinical implication, overt hyperthyroidism is associated with thyroid cancer in both men and women. Within the euthyroid range, the highest tertile of TSH was associated with a lower risk of thyroid cancer than the lowest TSH tertile and the highest FT4 tertile was associated with a higher risk of thyroid cancer than the lowest FT4 tertile in both men and women. Our finding indicates that low levels of TSH and high levels of FT4, even within the normal range, were associated with an increased risk of incident thyroid cancer.

6 July 2011 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
SHSeok Jin Hong
Seok Jin Hong
SLSang Hyuk Lee
Sang Hyuk Lee
SJSung Min Jin
Sung Min Jin
SKSoon Young Kwon
Soon Young Kwon
KJKwang Yoon Jung
Kwang Yoon Jung
KLKyo Won Lee
Kyo Won Lee
Conclusion: Injection of injured rabbit vocal folds with human adipose-derived stem cells (hADSCs) led to improved wound healing and fewer signs of scarring as demonstrated by a decreased collagen content in the treated folds compared with the untreated folds. hADSCs remained viable for up to 12 weeks in rabbit vocal folds. Objective: The aim of this study was to investigate the morphologic and histologic properties of scarred rabbit vocal folds following injection of hADSCs. Methods: This was a randomized, controlled animal study. Twenty-four vocal folds from 12 New Zealand rabbits were scarred using a CO2 laser and injected with either hADSCs (left vocal fold) or phosphate-buffered saline (right vocal fold). Every 4 weeks for the first 12 weeks after injection, an endoscopic examination was performed to assess the morphology of the vocal folds. Twelve weeks later the animals were euthanized and the tissues were stained for histology. Results: In comparison with the right vocal folds, there was significantly less granulation tissue in the hADSCs-injected left vocal folds (p < 0.05). Histological examination revealed excessive collagen deposition and perichondral fibrosis in the right vocal folds, whereas the left vocal folds exhibited better wound healing and less collagen deposition (p < 0.05). Among the 12 specimens injected with hADSCs, 4 specimens demonstrated viable hADSCs under immunofluorescent cytochemistry.

13 October 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
CPChul-Hyun Park
Chul-Hyun Park
KYKyung Jae Yoon
Kyung Jae Yoon
YLYong-Taek Lee
Yong-Taek Lee
SJSung Min Jin
Sung Min Jin
SLSang Hyuk Lee
Sang Hyuk Lee
TKTae Hwan Kim
Tae Hwan Kim
The relationship between low muscle mass (LMM) with obesity and hearing loss has been poorly studied. We aimed to investigate the association of LMM and obesity on hearing loss in the general population. A total of 265,792 adults who underwent a hearing test and body composition analyses were included. Pre-sarcopenia was defined as having an appendicular muscle mass index <5.7 kg/m2 for women and <7.0 kg/m2 for men, and obesity as a body mass index ≥25 kg/m2, while pre-sarcopenic obesity was defined as the co-presence of LMM and obesity. Participants were divided into four groups according to the presence of pre-sarcopenia and/or obesity. The prevalence of hearing loss was 1.8% in the control, 2.5% in the pre-sarcopenia alone, 3.0% in the obesity alone, and 6.2% in the pre-sarcopenic obesity group (p < 0.001). Hearing Thresholds were the highest in the pre-sarcopenic obesity group compared with the other three groups. In multivariable-adjusted models, the risk of hearing loss was the highest in the pre-sarcopenic obesity group (odds ratio: 1.30 [95% confidence interval: 1.10–1.56]), followed by the obesity alone (1.20 [1.12–1.28]) and pre-sarcopenia alone (1.19 [1.06–1.34]) group compared with the control group (p < 0.001). Pre-sarcopenic obesity was independently associated with a higher prevalence of hearing loss, supporting pre-sarcopenic obesity itself as a risk for the decline in hearing function.

8 November 2008 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
KLKyung Chul Lee
Kyung Chul Lee
SLSeung Suk Lee
Seung Suk Lee
JLJong Kyu Lee
Jong Kyu Lee
SLSang Hyuk Lee
Sang Hyuk Lee